Perakizumab is a humanized IgG1_ monoclonal antibody directed against IL-17A. Perakizumab acts as an immunomodulator with the potential for the treatment of autoimmune diseases including psoriatic arthritis.
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.